{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:08:58Z","timestamp":1740164938270,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Econ Rev"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Neuromuscular blockade and pneumoperitoneum (PP) are important factors to ensure successful laparoscopic surgery. However, residual neuromuscular blockade (rNMB) and PP are associated with many unfavorable complications. The aim of this study is to compare the cost-effectiveness of using sugammadex versus neostigmine in laparoscopic surgery in China.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A decision tree model was developed with a time horizon based on laparoscopic surgery related hospitalization duration. 2000 patients using sugammadex or neostigmine were simulated within the model. The model outcomes included incidence of rNMB and PP related complications and their treatment costs. Data on clinical efficacy, safety and cost were collected from published literature and interviews of physicians.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The model projected that treatment with sugammadex instead of neostigmine would lead to 673 fewer total complications, including rNMB\/PP related complications, hospitalization, and other AEs (621 events versus 1294 events, respectively). Use of sugammadex was associated with an incremental medication cost of \u00a51,360,410. However, 93.6% of the increased medication cost can be off-set by the reduced costs attributable to treatment of rNMB related complications, PP related complications, hospitalization and other adverse events in sugammadex group. In aggregate, the sugammadex group incurred an incremental cost of \u00a586,610 to prevent 673 complications, (\u00a5128.56 per one rNMB\/PP related complications prevention). One-way sensitivity analysis confirmed the robustness of the model.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Use of sugammadex in replacement of neostigmine would result in significantly lower rNMB\/PP related complications but at a substantially higher medication cost. Upon accounting for the costs associated with treatment of rNMB\/PP related complications, 93.6% of medication cost is projected to be offset. In balance, sugammadex appears to offer good value for reversal of neuromuscular blockade for laparoscopic surgery in China.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13561-020-00292-x","type":"journal-article","created":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T16:02:33Z","timestamp":1605369753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China"],"prefix":"10.1186","volume":"10","author":[{"given":"Maodong","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-1813","authenticated-orcid":false,"given":"Jianwei","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,14]]},"reference":[{"issue":"1","key":"292_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1213\/ANE.0b013e3181da832d","volume":"111","author":"GS Murphy","year":"2010","unstructured":"Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111(1):120\u20138.","journal-title":"Anesth Analg"},{"issue":"1","key":"292_CR2","first-page":"1","volume":"32","author":"Y Buwei","year":"2015","unstructured":"Buwei Y, et al. Incidence of postoperative residual neuromuscular blockade after general anesthesia: a prospective, multicenter, anesthetists-blind, observational study. Curr Med Res Opin. 2015;32(1):1.","journal-title":"Curr Med Res Opin"},{"key":"292_CR3","unstructured":"Wu, X. Expert Consensus on Rational Drug Use in Clinical Practice for Neuromuscular Blockade (2017 Edition). Beijing: People's Medical Publishing House (PMPH)., 2017."},{"key":"292_CR4","volume-title":"Low pressure gynecological laparoscopy (7 mmHg) with AirSeal1 system versus a standard insufflation (15 mmHg): a pilot study in 60 patients","author":"J Sroussi","year":"2017","unstructured":"Sroussi J. Low pressure gynecological laparoscopy (7 mmHg) with AirSeal1 system versus a standard insufflation (15 mmHg): a pilot study in 60 patients; 2017."},{"issue":"10","key":"292_CR5","first-page":"981","volume":"28","author":"J Hu","year":"2012","unstructured":"Hu J, Zhang R, Bao H, et al. Impact of different intra-abdominal pressure on hemodynamic changes monitored by FloTrac\/Vigileo in laparoscopic gynecological surgery patient. J Clin Anesth. 2012;28(10):981\u20134.","journal-title":"J Clin Anesth"},{"issue":"1","key":"292_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2253-14-1","volume":"14","author":"X Wu","year":"2014","unstructured":"Wu X, et al. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects. BMC Anesthesiol. 2014;14(1):1\u201310.","journal-title":"BMC Anesthesiol"},{"key":"292_CR7","first-page":"408","volume":"5","author":"B Yu","year":"2014","unstructured":"Yu B, Wang X, Helbo-Hansen HS, Huang WQ, Askeland B, et al. Sugammadex 4.0 mg kg\u20131 reversal of deep Rocuronium-induced neuromuscular blockade: a multicenter study in Chinese and Caucasian patients. J Anesth Clin Res. 2014;5:408.","journal-title":"J Anesth Clin Res"},{"key":"292_CR8","doi-asserted-by":"crossref","unstructured":"Chambers D, Paulden M, Paton F, Heirs M, Duffy S, Craig D, et al. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment. Health Technol Assess. 2010;14(39):1-211.","DOI":"10.3310\/hta14390"},{"issue":"Issue 1","key":"292_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CEOR.S100921","volume":"8","author":"M Carron","year":"2016","unstructured":"Carron M, Baratto F, Zarantonello F, et al. Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center. Clinicoecon Outcomes Res Ceor. 2016;8(Issue 1):43\u201352.","journal-title":"Clinicoecon Outcomes Res Ceor"},{"issue":"12","key":"292_CR10","first-page":"1267","volume":"82","author":"CL Errando","year":"2016","unstructured":"Errando CL, Garutti I, Mazzinari G, et al. Residual neuromuscular blockade in the postanesthesia care unit. Observational cross-sectional study of a multicenter cohort. Minerva Anestesiol. 2016;82(12):1267.","journal-title":"Minerva Anestesiol"},{"key":"292_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/00000542-200004000-00014","volume":"92","author":"E Sundman","year":"2000","unstructured":"Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology. 2000;92:977\u201384.","journal-title":"Anesthesiology"},{"issue":"4","key":"292_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.redar.2012.12.011","volume":"60","author":"M Norton","year":"2013","unstructured":"Norton M, Xar\u00e1 D, Parente D, et al. Residual neuromuscular block as a risk factor for critical respiratory events in the post anesthesia care unit. Rev Esp Anestesiol Reanim. 2013;60(4):191.","journal-title":"Rev Esp Anestesiol Reanim"},{"issue":"23","key":"292_CR13","first-page":"188","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhang Q, Li L, Wang S. Length of stay in intensive care unit and total cost with midazolam combined with fentanyl among intubated patients with type II AECOPD respiratory failure. China Pract Med. 2015;10(23):188\u2013189.3.","journal-title":"China Pract Med"},{"issue":"1","key":"292_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2253-14-1","volume":"14","author":"X Wu","year":"2014","unstructured":"Wu X, Oerding H, Liu J, et al. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects[J]. BMC Anesthesiol. 2014;14(1):1\u201310.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"292_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.amjsurg.2013.09.027","volume":"208","author":"J Hua","year":"2014","unstructured":"Hua J, Gong J, Yao L, et al. Low-pressure versus standard-pressure pneumoperitoneum for laparoscopic cholecystectomy: a systematic review and meta-analysis. Am J Surg. 2014;208(1):143\u201350.","journal-title":"Am J Surg"},{"issue":"16","key":"292_CR16","first-page":"64","volume":"29","author":"X Jia","year":"2010","unstructured":"Jia X, Dong Y. Comparative analysis of length of stay and total cost between traditional surgical approach and laparoscopy. China Foreign Med Treat. 2010;29(16):64\u20135.","journal-title":"China Foreign Med Treat"},{"issue":"Issue 1","key":"292_CR17","first-page":"317","volume":"8","author":"RE De","year":"2016","unstructured":"De RE, et al. The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact. Clinicoecon Outcomes Res Ceor. 2016;8(Issue 1):317\u201322.","journal-title":"Clinicoecon Outcomes Res Ceor"},{"issue":"6","key":"292_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5152\/TJAR.2015.35682","volume":"43","author":"DY \u00dcnal","year":"2015","unstructured":"\u00dcnal DY, Baran \u0130, Mutlu M, et al. Comparison of Sugammadex versus Neostigmine Costs and Respiratory Complications in Patients with Obstructive Sleep Apnoea. Turk J Anaesthesiol Reanim. 2015;43(6):387.","journal-title":"Turk J Anaesthesiol Reanim"}],"container-title":["Health Economics Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-020-00292-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13561-020-00292-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-020-00292-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T16:03:46Z","timestamp":1605369826000},"score":1,"resource":{"primary":{"URL":"https:\/\/healtheconomicsreview.biomedcentral.com\/articles\/10.1186\/s13561-020-00292-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,14]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1186\/s13561-020-00292-x","relation":{},"ISSN":["2191-1991"],"issn-type":[{"type":"electronic","value":"2191-1991"}],"subject":[],"published":{"date-parts":[[2020,11,14]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author Maodong Ren receives research support fees from MSD and MSD has a sugammadex drug called Bridion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}